Expanding the reach of highly potent cancer therapies with pre|CISION®

We believe in hope
without compromise

Our Science

The pre|CISION® peptide drug conjugate platform. >

Partnering

Avacta is seeking to expand its partnerships for targeted cancer therapies. >

R&D Spotlight Series

Watch the videos from our Research & Development Spotlight Series  >